Decoding the human bone metastatic niche at single-cell resolution: convergent ecosystems, therapeutic vulnerabilities, and the spatial frontier

Bone metastases arise from biologically diverse solid malignancies but develop within a shared and highly specialized skeletal microenvironment. Recent advances in single-cell transcriptomics have enabled direct characterization of human bone metastatic lesions and have shifted the field from tumor-specific descriptions toward cross-cancer ecosystem models. Emerging pan-cancer atlases reveal partial convergence across malignancies, including recurrent suppressive myeloid states, transcriptionally defined T Cell exhaustion programs, remodeled stromal and osteolineage compartments, specialized endothelial niches, and distinct malignant-cell programs observed in bone. Several of these ecosystem features nominate candidate therapeutic vulnerabilities rather than established dependencies. Combined immune-checkpoint blockade, modulation of osteoimmune macrophage states, and disruption of stromal chemokine signaling have each received different levels of support, ranging from transcriptomic or spatial association to in vitro and in vivo perturbation, while prospective clinical validation is lacking. Because recurrence across analytical studies is not equivalent to independent replication or bone specificity, we distinguish cross-cancer recurrence from bone enrichment and from mechanistically supported skeletal-niche adaptation. Current datasets also reveal substantial heterogeneity between patients, tumor types, anatomical compartments, treatment exposures, and analytical frameworks, arguing against a single universal bone metastatic niche. This mini review synthesizes the rapidly evolving human single-cell literature on established bone metastases, evaluates candidate niche-associated therapeutic vulnerabilities, and outlines the spatial and functional validation required for clinical translation.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-12
DOI
https://doi.org/10.3389/fcell.2026.1999858
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Decoding the human bone metastatic niche at single-cell resolution: convergent ecosystems, therapeutic vulnerabilities, and the spatial frontier

Mohammad Khaldoun Al Masri, Abderrahman Ouban, Wael Al-Kattan, Mohamad Bakir
Frontiers in Cell and Developmental Biology
Cancer Cells and Metastasis
article

Decoding the human bone metastatic niche at single-cell resolution: convergent ecosystems, therapeutic vulnerabilities, and the spatial frontier

Mohammad Khaldoun Al Masri, Abderrahman Ouban, Wael Al-Kattan, Mohamad Bakir
article en

Abstract

Bone metastases arise from biologically diverse solid malignancies but develop within a shared and highly specialized skeletal microenvironment. Recent advances in single-cell transcriptomics have enabled direct characterization of human bone metastatic lesions and have shifted the field from tumor-specific descriptions toward cross-cancer ecosystem models. Emerging pan-cancer atlases reveal partial convergence across malignancies, including recurrent suppressive myeloid states, transcriptionally defined T Cell exhaustion programs, remodeled stromal and osteolineage compartments, specialized endothelial niches, and distinct malignant-cell programs observed in bone. Several of these ecosystem features nominate candidate therapeutic vulnerabilities rather than established dependencies. Combined immune-checkpoint blockade, modulation of osteoimmune macrophage states, and disruption of stromal chemokine signaling have each received different levels of support, ranging from transcriptomic or spatial association to in vitro and in vivo perturbation, while prospective clinical validation is lacking. Because recurrence across analytical studies is not equivalent to independent replication or bone specificity, we distinguish cross-cancer recurrence from bone enrichment and from mechanistically supported skeletal-niche adaptation. Current datasets also reveal substantial heterogeneity between patients, tumor types, anatomical compartments, treatment exposures, and analytical frameworks, arguing against a single universal bone metastatic niche. This mini review synthesizes the rapidly evolving human single-cell literature on established bone metastases, evaluates candidate niche-associated therapeutic vulnerabilities, and outlines the spatial and functional validation required for clinical translation.

Frontiers in Cell and Developmental BiologyVol. 14
Alfaisal University (SA)
Good health and well-being
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon